The ANA Q&A

ANA2022 Plenary Session Spotlight: Krishnankutty Sathian, MBBS, PhD, FANA and Stefanie Geisler, MD | Neurodegeneration

Neurodegeneration: Focusing on root causes and interconnections

“Novel Perspectives on Neurodegeneration,” the first plenary session at ANA2022, takes place Sunday, October 23, from 9:15 to 11:30 a.m. Register now to attend the Annual Meeting in Chicago!

ANA2022 Plenary Session Spotlight: Annapurna Poduri, MD, MPH, and Sattar Khoshkoo, MD | Somatic Mutations in Neurological Disease

Mutations Under the Radar: A Patchwork of Somatic Variation May Drive Neurologic Disease

The ANA2022 plenary session, “Emerging Role of Somatic Mutations in Neurology,” will take place Monday, October 24, 2022, from 8:45 to 10:45 a.m. Register now to attend the Annual Meeting in Chicago!

The ANA Q&A: Dr. Eva Feldman

For this month’s ANA Q&A, we are featuring ALS Awareness Month, and we spoke with Eva Feldman, MD, PhD, FANA. Dr. Feldman is the Russell N. DeJong Professor of Neurology at Michigan Medicine, where she also serves as Director of the ALS Center of Excellence and Director of the NeuroNetwork for Emerging Therapies.